Literature DB >> 27021683

MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression.

Yanwei Zhang1, Jing Xu2.   

Abstract

miR-140-5p is down-regulated in patients with pulmonary arterial hypertension (PAH) and experimental models of PAH, and inhibits hypoxia-mediated pulmonary artery smooth muscle cell (PASMC) proliferation in vitro. Delivery of synthetic miR-140-5p prevents and treats established, experimental PAH. DNA methyltransferase 1 (Dnmt1) is up-regulated in PAH associated human PASMCs (HPASMCs), which promotes the development of PAH by hypermethylation of CpG islands within the promoter for superoxide dismutase 2 (SOD2) and down-regulating SOD2 expression. We searched for miR-140-5p targets using TargetScan, PicTar and MiRanda tools, and found that Dnmt1 is a potential target of miR-140-5p. Based on these findings, we speculated that miR-140-5p might target Dnmt1 and regulate SOD2 expression to regulate hypoxia-mediated HPASMC proliferation, apoptosis and differentiation. We detected the expression of miR-140-5p, Dnmt1 and SOD2 by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot assays, respectively, and found down-regulation of miR-140-5p and SOD2 and up-regulation of Dnmt1 exist in PAH tissues and hypoxia-mediated HPASMCs. Cell proliferation, apoptosis and differentiation detection showed that miR-140-5p inhibits proliferation and promotes apoptosis and differentiation of HPASMCs in hypoxia, while the effect of Dnmt1 on hypoxia-mediated HPASMCs is reversed. Luciferase assay confirmed that miR-140-5p targets Dnmt1 directly. An inverse correlation is also found between miR-140-5p and Dnmt1 in HPASMCs. In addition, we further investigated whether miR-140-5p and Dnmt1 regulate HPASMC proliferation, apoptosis and differentiation by regulating SOD2 expression, and the results confirmed our speculation. Taken together, these results indicated that miR-140-5p at least partly targets Dnmt1 and regulates SOD2 expression to inhibit proliferation and promote apoptosis and differentiation of HPASMCs in hypoxia.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methyltransferase 1; Pulmonary arterial hypertension; Superoxide dismutase 2; miR-140-5p

Mesh:

Substances:

Year:  2016        PMID: 27021683     DOI: 10.1016/j.bbrc.2016.03.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  The roles of microRNAs played in lung diseases via regulating cell apoptosis.

Authors:  Qiaoling Huang; Li Chen; Qinqin Bai; Ting Tong; You Zhou; Zhongyu Li; Chunxue Lu; Shenghua Chen; Lili Chen
Journal:  Mol Cell Biochem       Date:  2021-08-16       Impact factor: 3.396

2.  Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment.

Authors:  Jingjing Wang; Rong Jiang; Yanlin Tan; Kuan Cheng
Journal:  Cell Cycle       Date:  2022-03-04       Impact factor: 5.173

3.  MiR-665 regulates VSMCs proliferation via targeting FGF9 and MEF2D and modulating activities of Wnt/β-catenin signaling.

Authors:  Kai Li; Jin Pan; Jianjun Wang; Fengrui Liu; Li Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 4.  Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension.

Authors:  Chenggui Miao; Jun Chang; Guoxue Zhang
Journal:  Mol Biol Rep       Date:  2018-10-08       Impact factor: 2.316

5.  Prediction of target genes for miR-140-5p in pulmonary arterial hypertension using bioinformatics methods.

Authors:  Fangwei Li; Wenhua Shi; Yixin Wan; Qingting Wang; Wei Feng; Xin Yan; Jian Wang; Limin Chai; Qianqian Zhang; Manxiang Li
Journal:  FEBS Open Bio       Date:  2017-10-21       Impact factor: 2.693

6.  Role of RASEF hypermethylation in cigarette smoke-induced pulmonary arterial smooth muscle remodeling.

Authors:  Qinghai Li; Jixing Wu; Yongjian Xu; Lu Liu; Jungang Xie
Journal:  Respir Res       Date:  2019-03-07

7.  miR-140-5p regulates the odontoblastic differentiation of dental pulp stem cells via the Wnt1/β-catenin signaling pathway.

Authors:  Xiaohui Lu; Xi Chen; Jing Xing; Min Lian; Dan Huang; Yuanzhou Lu; Guijuan Feng; Xingmei Feng
Journal:  Stem Cell Res Ther       Date:  2019-07-29       Impact factor: 6.832

Review 8.  Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.

Authors:  R C P Luna; Y de Oliveira; J V C Lisboa; T R Chaves; T A M de Araújo; E E de Sousa; M Miranda Neto; L Pirola; V A Braga; J L de Brito Alves
Journal:  Braz J Med Biol Res       Date:  2018-10-18       Impact factor: 2.590

9.  Upregulation of miRNA-140-5p inhibits inflammatory cytokines in acute lung injury through the MyD88/NF-κB signaling pathway by targeting TLR4.

Authors:  Ye Yang; Dongdong Liu; Yin Xi; Juan Li; Bin Liu; Junjie Li
Journal:  Exp Ther Med       Date:  2018-09-04       Impact factor: 2.447

10.  miR‑140‑5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA.

Authors:  Min Liu; Huimin Liu; Jing Zhou; Zhuojun Yu
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.